8 news items
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
PYXS
SNDX
10 Jun 24
and immune evasion. Pyxis Oncology's ADC and immuno-oncology (IO) programs employ novel and emerging strategies to target a broad range of solid
Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
PYXS
30 May 24
ADC and immuno-oncology (IO) programs employ novel and emerging strategies to target a broad range of solid tumors resistant to current standards
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
PYXS
14 May 24
continues to support go-forward monotherapy and potential combination development strategies." Pyxis Oncology continues to expand
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
PYXS
9 May 24
) programs employ novel and emerging strategies to target a broad range of solid tumors resistant to current standards of care. To learn more, visit
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
ABAT
ABIO
ACORQ
3 Apr 24
strategy including a stock buyback program of up to $5 million.
Next.e.GO N.V
6zhw1eca85s133pw6ktjxp09y14hlpgwdhx7zx0pn1meow 2hlx4a7vb5m
PYXS
28 Mar 24
-oncology (IO) programs employ novel and emerging strategies to target a broad range of solid tumors resistant to current standards of care. To learn more
shtf3xrwz6xdqzbd45n3rwc3at2t68a7apbi0ljdkm81g9
PYXS
27 Mar 24
-oncology (IO) programs employ novel and emerging strategies to target a broad range of solid tumors resistant to current standards of care. To learn more
a5pomzeezkw78vuibvyzahot6n thl3ou8tcdr0yjaudz2wduouwqq5fy
PYXS
21 Mar 24
and immune evasion. Pyxis Oncology's ADC and immuno-oncology (IO) programs employ novel and emerging strategies to target a broad range of solid
- Prev
- 1
- Next